Battegay, Manuel and Arasteh, Keikawus and Plettenberg, Andreas and Bogner, Johannes R. and Livrozet, Jean-Michel and Witt, Mallory D. and Mossdorf, Erik and Yong, Chan-Loi and Zhang, Wei and Macha, Sreeraj and Berger, Frank and Stern, Jerry and Robinson, Patrick and Quinson, Anne-Marie. (2011) Bioavailability of extended-release nevirapine 400 and 300 mg in HIV-1 : a multicenter, open-label study. Clinical therapeutics, Vol. 33, H. 9. pp. 1308-1320.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6004769
Downloads: Statistics Overview
Abstract
Nevirapine (NVP) is a widely used non-nucleoside reverse transcriptase inhibitor. A once-daily extended-release (XR) formulation would potentially increase adherence and thus efficacy.
| Faculties and Departments: | 03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Infection Biology (Khanna) |
|---|---|
| UniBasel Contributors: | Battegay, Manuel E. |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | Excerpta Medica |
| ISSN: | 0149-2918 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Identification Number: | |
| Last Modified: | 16 Aug 2013 07:34 |
| Deposited On: | 16 Aug 2013 07:32 |
Repository Staff Only: item control page